A detailed history of Abrdn PLC transactions in Argenx Se stock. As of the latest transaction made, Abrdn PLC holds 67,262 shares of ARGX stock, worth $42 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
67,262
Previous 91,348 26.37%
Holding current value
$42 Million
Previous $39.3 Million 7.14%
% of portfolio
0.07%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$434.22 - $551.9 $10.5 Million - $13.3 Million
-24,086 Reduced 26.37%
67,262 $36.5 Million
Q2 2024

Aug 09, 2024

BUY
$356.01 - $451.55 $2.11 Million - $2.67 Million
5,917 Added 6.93%
91,348 $39.3 Million
Q1 2024

May 08, 2024

BUY
$356.95 - $413.29 $4.27 Million - $4.94 Million
11,955 Added 16.27%
85,431 $33.6 Million
Q4 2023

Jan 31, 2024

BUY
$338.91 - $506.01 $24.9 Million - $37.2 Million
73,476 New
73,476 $28 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.5B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.